Don't Jump to Spiriva First-Line for Mild COPD

December 2017

New evidence will spark controversy over how to treat COPD patients with MILD disease.

About seven in 10 COPD patients have early disease with minimal symptoms. But meds are usually studied in moderate to severe COPD.

Now evidence suggests that Spiriva (tiotropium), a long-acting muscarinic antagonist (LAMA), may be beneficial for mild COPD.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Vaccines Immunize Against Shingles With the New Vaccine, Shingrix
COPD Don't Jump to Spiriva First-Line for Mild COPD
NSAIDs Choose a Chronic NSAID Based on Safety
Acne Don't Use Oral Antibiotics Long-Term for Acne
Cardiology Look for Heart Failure Patients Who May Need an Aldosterone Antagonist
Insulin Fiasp (Insulin Aspart) Will Be Another Mealtime Insulin Alternative
Constipation Emphasize an Effective Bowel Regimen for Opioid-Induced Constipation
Supplements Tell Diabetes Patients Not to Rely on Cinnamon
Gastroenterology Know When to Hold Meds Before Colonoscopy
Infectious Diseases Don't Consider Antibiotics for Most Patients With Acute Infectious Diarrhea